These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2827688)

  • 1. Interference of eicosapentaenoic and docosahexaenoic acids with arachidonate-and U46619-induced platelet activation and desensitization.
    Hatmi M; Lussiana JP; Junien JL; Burke J; Vargaftig BB
    Biochem Pharmacol; 1988 Feb; 37(3):481-9. PubMed ID: 2827688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet desensitization induced by arachidonic acid is not due to cyclo-oxygenase inactivation and involves the endoperoxide receptor.
    Carmo LG; Hatmi M; Rotilio D; Vargaftig BB
    Br J Pharmacol; 1985 Aug; 85(4):849-59. PubMed ID: 2994786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fish oil fatty acids and human platelets: dose-dependent decrease in dienoic and increase in trienoic thromboxane generation.
    Krämer HJ; Stevens J; Grimminger F; Seeger W
    Biochem Pharmacol; 1996 Oct; 52(8):1211-7. PubMed ID: 8937428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interference of the thromboxane antagonist SK&F 88046 with platelet activation and subsequent desensitization by arachidonic acid and the thromboxane mimetics U46619 and EP171.
    Vargaftig B; Joseph D; Hatmi M
    Thromb Res; 1987 May; 46(4):509-17. PubMed ID: 3039684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eicosapentaenoic acid and docosahexaenoic acid are antagonists at the thromboxane A2/prostaglandin H2 receptor in human platelets.
    Swann PG; Venton DL; Le Breton GC
    FEBS Lett; 1989 Jan; 243(2):244-6. PubMed ID: 2537230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of sulfinpyrazone and its metabolite G25671 on platelet activation and desensitization and on bronchoconstriction induced by the prostaglandin endoperoxide analog U46619.
    Hatmi M; del Maschio A; Lefort J; de gaetano G; Vargaftig BB; Cerletti C
    J Pharmacol Exp Ther; 1987 May; 241(2):623-7. PubMed ID: 3106620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation by cyclic AMP of arachidonic acid-induced platelet desensitization.
    Hatmi M; Rotilio D; Haye B; Antonicelli F; Joseph D; Vargaftig BB
    Eur J Pharmacol; 1986 Dec; 132(2-3):219-28. PubMed ID: 3028837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet desensitization by arachidonic acid is associated with the suppression of endoperoxide/thromboxane A2 binding to the membrane receptor.
    Sato T; Hashizume T; Nakao K; Akiba S; Fujii T
    Biochim Biophys Acta; 1989 Aug; 992(2):168-73. PubMed ID: 2503041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
    Ohkubo S; Nakahata N; Ohizumi Y
    Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal platelet response to thromboxane A2.
    Wu KK; Le Breton GC; Tai HH; Chen YC
    J Clin Invest; 1981 Jun; 67(6):1801-4. PubMed ID: 6263954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desensitization of platelet thromboxane A2/prostaglandin H2 receptors by the mimetic U46619.
    Liel N; Mais DE; Halushka PV
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1133-8. PubMed ID: 2974487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the inhibition of U46619-mediated human platelet activation by the trimetoquinol isomers. Evidence for endoperoxide/thromboxane A2 receptor blockade.
    Ahn CH; Romstedt KJ; Wallace LJ; Miller DD; Feller DR
    Biochem Pharmacol; 1988 Aug; 37(15):3023-33. PubMed ID: 3134894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thrombocyte interaction with a collagen substrate: the role of thrombocyte-synthesized prostaglandin endoperoxides and thromboxane A2].
    Mazurov AB; Leĭtin VL; Repin VS
    Biull Eksp Biol Med; 1984 Nov; 98(11):563-6. PubMed ID: 6439262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arachidonate is an antagonist of platelet activation by the endoperoxide analog U46619.
    Huang EM; Detwiler TC
    Biochim Biophys Acta; 1982 Apr; 715(2):246-9. PubMed ID: 6803846
    [No Abstract]   [Full Text] [Related]  

  • 15. The cleavage of plasmenylethanolamine by phospholipase A2 appears to be mediated by the low affinity binding site of the TxA2/PGH2 receptor in U46619-stimulated human platelets.
    Turini ME; Holub BJ
    Biochim Biophys Acta; 1994 Jun; 1213(1):21-6. PubMed ID: 8011675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet prostanoids in interaction of platelets with collagen substrates. II. Effects of exogenous arachidonic acid, stable PG endoperoxides analogue, and aspirin.
    Mazurov AV; Leytin VL; Repin VS; Taube C; Förster W
    Biomed Biochim Acta; 1984; 43(8-9):S373-6. PubMed ID: 6440553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of stearidonic acid (18:4 n-3) on platelet aggregation and arachidonate oxygenation.
    Kockmann V; Spielmann D; Traitler H; Lagarde M
    Lipids; 1989 Dec; 24(12):1004-7. PubMed ID: 2559279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fish oil preparations rich in docosahexaenoic acid modify platelet responsiveness to prostaglandin-endoperoxide/thromboxane A2 receptor agonists.
    Scheurlen M; Kirchner M; Clemens MR; Jaschonek K
    Biochem Pharmacol; 1993 Jul; 46(2):245-9. PubMed ID: 8347146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of propranolol, pindolol, practolol and talinolol on arachidonic acid (AA)- and U-46619-induced aggregation and on AA-induced thromboxane A2 formation in platelets.
    Heinroth I; Block HU; Pönicke K; Förster W
    Prostaglandins Leukot Med; 1983 Oct; 12(2):189-206. PubMed ID: 6139824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
    Greenberg SS; Johns A; Kleha J; Xie J; Wang Y; Bianchi J; Conley K
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1352-61. PubMed ID: 8138950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.